Search for: "Mylan Pharmaceuticals, Inc" Results 61 - 80 of 496
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jul 2020, 9:40 am by Lawrence B. Ebert
For the reasons described below, we affirm.The matters at issue:In 2016, Takeda sued Mylan Pharmaceuticals Inc. forpatent infringement based on Mylan’s recently submittedAbbreviated New Drug Application (“ANDA”) for a genericversion of Takeda’s Colcrys® product, which is a brandedversion of the drug colchicine. [read post]
Mylan Pharmaceuticals, Inc., the Federal Circuit reversed the District Court of New Jersey’s grant of summary judgement in favor of Valeant that claim 8 of U.S. [read post]
5 Apr 2020, 9:57 pm by Patent Docs
Mylan Pharmaceuticals Inc., the Federal Circuit reversed a decision by the U.S. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
Eco-Gel 200 ultrasound gel has been recalled by Eco-Med Pharmaceutical, Inc. due to bacterial contamination. [read post]
18 Feb 2020, 4:00 am by Martin Kratz
Pfizer Canada ULC, 2020 FC 1, at para. 42. [3] See Sections 27(3)(b) and 28.3 of the Patent Act, RSC 1985, c P-4 [4] Burton Parsons Chemicals, Inc v Hewlett-Packard (Canada) Ltd, [1976] 1 SCR 555 at 563 [5] Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61 at paragraph 37, [2008] 3 SCR 265; see also Bell Helicopter Textron Canada Limitée v Eurocopter, société par actions simplifiée, 2013 FCA 219 at paragraph 65; Mylan… [read post]
9 Jan 2020, 8:25 pm by Brianna Smith
Mylan Pharmaceuticals Inc. is recalling certain batches of its Nizatidine Capsules, USP, over concerns they may contain a carcinogen. [read post]
13 Sep 2019, 11:09 am by Dennis Crouch
Mylan Pharmaceuticals Inc., 896 F.3d 1332 (Fed. [read post]
24 Jun 2019, 10:00 pm
Mylan Pharmaceuticals, Inc., 896 F.3d 1322 (Fed. [read post]
16 Jun 2019, 9:30 pm by Patent Docs
Mylan Pharmaceuticals Inc.), held that State sovereign immunity does not preclude institution of inter partes review proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
14 May 2019, 11:24 am by Lawrence B. Ebert
Mylan Labs., Inc., 464 F.3d 1286,1289 (Fed. [read post]
8 May 2019, 7:14 am by Rebecca Tushnet
” It’s not enough to put an unapproved drug on the market with a FDA-ish package insert, according to Mylan Labs., Inc. v. [read post]